STERIS Corporation receives clearance for VERIFY V24 biological indicator monitoring Sterrad Sterilization Systems
STERIS Corporation, a pioneer in low temperature sterilization, has received 510(k) clearance from the Food and Drug Administration (FDA) to market the VERIFY V24 Self-Contained Biological Indicator for routine biological monitoring of the standard cycles of the STERRAD 100S and STERRAD 200 Sterilization Systems; the Standard and Advanced Cycles of the STERRAD NX Sterilization System and the Express, Standard and Flex Scope Cycles of the 100NX Sterilization System.
In these applications, healthcare facilities can confidently utilize the VERIFY V24 Self Contained Biological Indicator as a permanent alternative to the STERRAD Cyclesure Biological Indicators; however, the VERIFY V24 SCBI is not intended to be used in test packs for any STERRAD cycles.
The VERIFY V24 Self-Contained Biological Indicator provides healthcare professionals with benefits such as: one biological indicator for use in multiple gaseous hydrogen peroxide systems and compliance with ANSI/AAMI/ISO 11138 and ANSI/AAMI ST58 standards.
When used in accordance with its full instructions for use, the VERIFY V24 Self-Contained Biological Indicator provides highly resistant microbial challenge for both the V-PRO Low Temperature and STERRAD Sterilization Systems. Visit STERIS for more information.